Deroy & Devereaux Private Investment Counsel Inc Novartis Ag Transaction History

Deroy & Devereaux Private Investment Counsel Inc

  • $1.75 Billion
  • Q3 2024

A detailed history of Deroy & Devereaux Private Investment Counsel Inc transactions in Novartis Ag stock. As of the latest transaction made, Deroy & Devereaux Private Investment Counsel Inc holds 2,075 shares of NVS stock, worth $201,441. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,075
Previous 2,175 4.6%
Holding current value
$201,441
Previous $232,000 3.02%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$106.13 - $120.89 $10,613 - $12,089
-100 Reduced 4.6%
2,075 $239,000
Q2 2024

Jul 29, 2024
SELL
$92.57 - $107.37 $18,514 - $21,474
-200 Reduced 8.42%
2,175 $232,000
Q4 2023

Jan 29, 2024
SELL
$92.27 - $101.54 $9,227 - $10,154
-100 Reduced 4.04%
2,375 $239,000
Q3 2023

Oct 30, 2023
SELL
$94.73 - $105.13 $18,946 - $21,026
-200 Reduced 7.48%
2,475 $252,000
Q1 2023

Apr 26, 2023
BUY
$80.03 - $92.81 $32,012 - $37,124
400 Added 17.58%
2,675 $246,000
Q4 2022

Jan 25, 2023
BUY
$75.55 - $92.52 $171,876 - $210,483
2,275 New
2,275 $206,000
Q4 2021

Jan 25, 2022
SELL
$79.7 - $88.13 $197,257 - $218,121
-2,475 Closed
0 $0
Q3 2020

Oct 22, 2020
SELL
$82.14 - $91.0 $16,428 - $18,200
-200 Reduced 7.48%
2,475 $215,000
Q2 2020

Jul 20, 2020
SELL
$80.93 - $91.1 $16,186 - $18,220
-200 Reduced 6.96%
2,675 $234,000
Q3 2019

Oct 23, 2019
SELL
$85.54 - $94.26 $4,277 - $4,713
-50 Reduced 1.71%
2,875 $250,000
Q1 2018

Apr 27, 2018
SELL
$70.39 - $84.15 $7,039 - $8,415
-100 Reduced 3.31%
2,925 $236,000
Q3 2017

Oct 25, 2017
BUY
$74.14 - $77.27 $224,273 - $233,741
3,025
3,025 $260,000

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Deroy & Devereaux Private Investment Counsel Inc Portfolio

Follow Deroy & Devereaux Private Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deroy & Devereaux Private Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Deroy & Devereaux Private Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email